PMC:7291971 / 5462-5917 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T101","span":{"begin":5,"end":10},"obj":"NCBITaxon:10239"},{"id":"T102","span":{"begin":98,"end":108},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T103","span":{"begin":113,"end":118},"obj":"NCBITaxon:10239"},{"id":"T104","span":{"begin":315,"end":318},"obj":"GO:0008541"},{"id":"T105","span":{"begin":372,"end":377},"obj":"PR:000002289"},{"id":"T106","span":{"begin":404,"end":413},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T107","span":{"begin":429,"end":433},"obj":"GO:0006272"}],"text":"rent viral RNA MTases which share a common Rossman fold organization [13]. The rarity of specific inhibitors for viral MTases constitutes a stimulating challenge for new antiviral therapy but also for functional studies of these fascinating enzymes.\nScheme 1 Schematic representation of the 2′-O-methylation of the cap structure at nucleoside N1 at 5′-end of mRNA to form Cap-1 RNA. General structure of compounds mimicking the 2′-O-methylation transition"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T29","span":{"begin":11,"end":14},"obj":"Body_part"},{"id":"T30","span":{"begin":359,"end":363},"obj":"Body_part"},{"id":"T31","span":{"begin":378,"end":381},"obj":"Body_part"}],"attributes":[{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A30","pred":"fma_id","subj":"T30","obj":"http://purl.org/sig/ont/fma/fma67122"},{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"rent viral RNA MTases which share a common Rossman fold organization [13]. The rarity of specific inhibitors for viral MTases constitutes a stimulating challenge for new antiviral therapy but also for functional studies of these fascinating enzymes.\nScheme 1 Schematic representation of the 2′-O-methylation of the cap structure at nucleoside N1 at 5′-end of mRNA to form Cap-1 RNA. General structure of compounds mimicking the 2′-O-methylation transition"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T41","span":{"begin":34,"end":35},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T42","span":{"begin":56,"end":68},"obj":"http://purl.obolibrary.org/obo/OBI_0000245"},{"id":"T43","span":{"begin":138,"end":139},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"rent viral RNA MTases which share a common Rossman fold organization [13]. The rarity of specific inhibitors for viral MTases constitutes a stimulating challenge for new antiviral therapy but also for functional studies of these fascinating enzymes.\nScheme 1 Schematic representation of the 2′-O-methylation of the cap structure at nucleoside N1 at 5′-end of mRNA to form Cap-1 RNA. General structure of compounds mimicking the 2′-O-methylation transition"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T62","span":{"begin":98,"end":108},"obj":"Chemical"},{"id":"T63","span":{"begin":170,"end":179},"obj":"Chemical"},{"id":"T64","span":{"begin":332,"end":342},"obj":"Chemical"}],"attributes":[{"id":"A62","pred":"chebi_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A63","pred":"chebi_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A64","pred":"chebi_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"}],"text":"rent viral RNA MTases which share a common Rossman fold organization [13]. The rarity of specific inhibitors for viral MTases constitutes a stimulating challenge for new antiviral therapy but also for functional studies of these fascinating enzymes.\nScheme 1 Schematic representation of the 2′-O-methylation of the cap structure at nucleoside N1 at 5′-end of mRNA to form Cap-1 RNA. General structure of compounds mimicking the 2′-O-methylation transition"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T16","span":{"begin":296,"end":307},"obj":"http://purl.obolibrary.org/obo/GO_0032259"},{"id":"T17","span":{"begin":433,"end":444},"obj":"http://purl.obolibrary.org/obo/GO_0032259"}],"text":"rent viral RNA MTases which share a common Rossman fold organization [13]. The rarity of specific inhibitors for viral MTases constitutes a stimulating challenge for new antiviral therapy but also for functional studies of these fascinating enzymes.\nScheme 1 Schematic representation of the 2′-O-methylation of the cap structure at nucleoside N1 at 5′-end of mRNA to form Cap-1 RNA. General structure of compounds mimicking the 2′-O-methylation transition"}

{"project":"2_test","denotations":[{"id":"32563813-23617634-29105572","span":{"begin":70,"end":72},"obj":"23617634"}],"text":"rent viral RNA MTases which share a common Rossman fold organization [13]. The rarity of specific inhibitors for viral MTases constitutes a stimulating challenge for new antiviral therapy but also for functional studies of these fascinating enzymes.\nScheme 1 Schematic representation of the 2′-O-methylation of the cap structure at nucleoside N1 at 5′-end of mRNA to form Cap-1 RNA. General structure of compounds mimicking the 2′-O-methylation transition"}

{"project":"LitCovid-sentences","denotations":[{"id":"T39","span":{"begin":75,"end":249},"obj":"Sentence"},{"id":"T40","span":{"begin":250,"end":382},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"rent viral RNA MTases which share a common Rossman fold organization [13]. The rarity of specific inhibitors for viral MTases constitutes a stimulating challenge for new antiviral therapy but also for functional studies of these fascinating enzymes.\nScheme 1 Schematic representation of the 2′-O-methylation of the cap structure at nucleoside N1 at 5′-end of mRNA to form Cap-1 RNA. General structure of compounds mimicking the 2′-O-methylation transition"}

{"project":"MyTest","denotations":[{"id":"32563813-23617634-29105572","span":{"begin":70,"end":72},"obj":"23617634"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"rent viral RNA MTases which share a common Rossman fold organization [13]. The rarity of specific inhibitors for viral MTases constitutes a stimulating challenge for new antiviral therapy but also for functional studies of these fascinating enzymes.\nScheme 1 Schematic representation of the 2′-O-methylation of the cap structure at nucleoside N1 at 5′-end of mRNA to form Cap-1 RNA. General structure of compounds mimicking the 2′-O-methylation transition"}